Neurocrine Biosciences shares owned by Motley Fool Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Motley Fool Asset Management
from 13F filings
Historical chart of Motley Fool Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Motley Fool Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Motley Fool Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $227k | 1.6k | 140.38 |
| 2025-06-30 | $335k | 2.7k | 125.69 |
| 2025-03-31 | $272k | 2.5k | 110.60 |
| 2024-12-31 | $307k | 2.2k | 136.50 |
| 2024-09-30 | $232k | 2.0k | 114.15 |
| 2024-06-30 | $288k | 2.1k | 140.11 |
| 2024-03-31 | $285k | 2.1k | 137.92 |
| 2023-12-31 | $246k | 1.9k | 131.76 |
| 2023-09-30 | $229k | 2.0k | 112.50 |
| 2022-12-31 | $206k | 1.7k | 119.44 |
| 2021-12-31 | $4.0k | 44 | 90.91 |
More positions owned by Motley Fool Asset Management
View all positions for Motley Fool Asset Management